Open Access
Subscription or Fee Access
An Overview on Analytical Estimation of Citicoline
Abstract
Keywords
References
Giménez R, Raïch J, Aguilar J (Nov 1991). "Changes in brain striatum dopamine and acetylcholine receptors induced by chronic CDP-choline treatment of aging mice". British Journal of Pharmacology. 104 (3): 575–8.
Cavun S, Savci V (Oct 2004). "CDP-choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvement". Fundamental & Clinical Pharmacology. 18 (5): 513–23.
Benson S, Arck PC, Tan S, Hahn S, Mann K, Rifaie N, Janssen OE, Schedlowski M, Elsenbruch S (Jun 2009). "Disturbed stress responses in women with polycystic ovary syndrome". Psychoneuroendocrinology. 34 (5): 727–35.
Florio P, Zatelli MC, Reis FM, degli Uberti EC, Petraglia F (2007). "Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders?". Frontiers in Bioscience. 12: 551–60.
Single-ingredient Preparations (: Citicoline). In: Martindale: The Complete Drug Reference [ed.by Sweetman S], 35th Ed. 2007, The Pharmaceutical Press: London (UK); e-version. .
Wurtman RJ, Regan M, Ulus I, Yu L (Oct 2000). "Effect of oral CDP-choline on plasma choline and uridine levels in humans". Biochemical Pharmacology. 60 (7): 989–92.
Alvarez XA, Sampedro C, Lozano R, Cacabelos R (Oct 1999). "Citicoline protects hippocampal neurons against apoptosis induced by brain beta-amyloid deposits plus cerebral hypoperfusion in rats". Methods and Findings in Experimental and Clinical Pharmacology. 21 (8): 535–40.
Carlezon WA, Pliakas AM, Parow AM, Detke MJ, Cohen BM, Renshaw PF (Jun 2002). "Antidepressant-like effects of cytidine in the forced swim test in rats". Biological Psychiatry. 51 (11): 882–9.
Tardner, P. (2020-08-30). "The use of Citicoline for the treatment of cognitive decline and cognitive impairment: A meta-analysis of pharmacological literature • International Journal of Environmental Science & Technology". International Journal of Environmental Science & Technology. Retrieved 2020-08-31.
Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC (2015). "The role of Citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives". Clin Interv Aging. 10: 1421–9.
Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, Harnett K, Schwiderski U, Gammans R (Nov 2000). "Effect of Citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators". Annals of Neurology. 48 (5): 713–22.
Saver JL (Fall 2008). "Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair". Reviews in Neurological Diseases. 5 (4): 167–77.
Sachan N, Chandra P, Yadav M, Pal D, Ghosh AK. Rapid analytical procedure for Citicoline in bulk and pharmaceutical dosage form by UV spectrophotometer. J Appl Pharm Sci 2011; 1:191–3.
Panda SS, Mohanta G, Kumar BV. Ravi estimation of Citicoline sodium in tablets by difference spectrophotometric method. J Chron Young Sci 2013; 4:18–20
Meenu Chaudhary, Kiran Bhardwaj and Praveen Kumar Analytical Method Development and Validation for Estimation of Citicoline In Bulk and Dosage Form by UV Spectroscopy, International Journal of Pharmacy and Biological Sciences, 120–125
Jimmi A.Patel et al. “Development and validation of a UV spectrophotometric method for estimation of Citicoline sodium in Bulk and Dosage Form”. Journal of Pharmacy Research 2010, 3(12),2876–2878.
Asma A. Pathan, Pappu M. Tarang, Prajakta S. Pattanshetty, Arwa A. Koita, Development and Validation of Difference Spectroscopic Method for Citicoline Sodium In Tablet Dosage Forms By Ultraviolet Spectroscopy, International Science and Technology Journal, Volume 7, Issue 3, 2018, 10–16
Bindaiya SK, Sahu K, Bahsare M, Kaethikeyn C, Moorthy NS, et al. Development and validation of an RP-HPLC method for determination of Citicoline monosodium in human plasma. Latin Am J Pharm 2010; 30:794–8
Derbouz S, Guermouche MH, Guremouche S. Stability- indicating HILIC method for the determination of Citicoline and characterization of its degradation by LC-MS/TOF, 1H, and 13C NMR. J Chromatographia 2017; 80:265–74
Minakshi Dhoru & Dharmesh Golwala, “New Analytical Method Development for Related Substances of Citicoline Sodium in Tablet Dosage Form” AEGAEUM JOURNAL, Volume 8, Issue 3, 2020: 493–503.
Maradiya HK, Pansara VH. Development and validation of reverse-phase high-performance liquid chromatography method for estimation of Citicoline sodium in bulk and dosage form. Indian J Pharm Sci 2013; 75:238–41
Patel VR, Prajapati AM. Development and validation of stability indicating assay method for analysis of Citicoline sodium by RP-HPLC. J Invent Rapid Pharm Anal Q Assur 2013;9(3):438–6
Bindaiya S, Argal A. Development and validation of RP-HPLC method for determination of Citicoline monosodium in pharmaceutical preparations. Int J Pharm Chem 2012; 2:85–8.
Surani S, Kabra P, Kimbahune R, Sunil K, Nargund LV. A reverse phase liquid chromatography analysis of Citicoline sodium in pharmaceutical dosage form using an internal standard method. Int J Pharm Technol Res 2012; 4:1136–41.
Uttarwar SO, Jadhav RT, Bonde CG. Stability indicating LC method for Citicoline sustained release tablet. Int J Pharm Technol Res 2010; 2:2482–6.
Ganduri RB, Peddareddigarui JR, Dasari NR, Saiempu RK. Stability indicating LC method for the determination of Citicoline sodium in injection formulation. Int J Pharm Technol Res 2010; 2:427–33.
Sharma OM, Chand T. Analytical method development and its validation for estimation of Citicoline sodium by reverse phase high-performance liquid chromatography (RP-HPLC). Int J Res Pharm Biomed Sci 2013; 4:550–8
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Research and Reviews: A Journal of Pharmaceutical Science